To us the most surprising result was the finding that anti-PD1/PD-L1 treatment of T1 tumor mice resulted in a significantly longer period of tumor regression (up to 31 days compared to less than 14 days in NP8 tumor mice). This evidence concerns the gene CD274 and neoplasm.